Cytosolic Hsp70 As a Biomarker to Predict Clinical Outcome in Patients with Glioblastoma

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Aug 21

PMID 31430337

Citations 10

Authors

Friederike Lammer

Claire Delbridge

Silvia Wurstle

Frauke Neff

Bernhard Meyer

Jurgen Schlegel

Kerstin A Kessel

Thomas E Schmid

Daniela Schilling

Stephanie E Combs

Affiliations

Soon will be listed here.

Abstract

Introduction: The major stress-inducible heat shock protein 70 (Hsp70) is induced after different stress stimuli. In tumors, elevated intracellular Hsp70 levels were associated on the one hand with radio- and chemotherapy resistance and on the other hand with a favorable outcome for patients. This study was undertaken to investigate cytosolic Hsp70 (cHsp70) as a potential biomarker for progression free (PFS) and overall survival (OS) in patients with primary glioblastomas (GBM).

Methods: The cHsp70 expression in tumor tissue of 60 patients diagnosed with primary GBM was analyzed by immunohistochemistry. The cHsp70 expression was correlated to the PFS and OS of the patients.

Results: A high cHsp70 expression was associated with a prolonged PFS (hazard ratio = 0.374, p = 0.001) and OS (hazard ratio = 0.416, p = 0.014) in GBM patients treated according to the standard Stupp protocol with surgery, radiotherapy and temozolomide.

Conclusions: These data suggest that the intracellular Hsp70 expression might serve as a prognostic marker in patients with primary GBM.

Citing Articles

Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme.

Cerono G, Melaiu O, Chicco D J Healthc Inform Res. 2024; 8(1):1-18.

PMID: 38273986 PMC: 10805687. DOI: 10.1007/s41666-023-00138-1.

Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials.

Babi A, Menlibayeva K, Bex T, Doskaliev A, Akshulakov S, Shevtsov M Cancers (Basel). 2022; 14(21).

PMID: 36358853 PMC: 9659111. DOI: 10.3390/cancers14215435.

Betulin and Its Derivatives Reduce Inflammation and COX-2 Activity in Macrophages.

Szlasa W, Slusarczyk S, Nawrot-Hadzik I, Abel R, Zalesinska A, Szewczyk A Inflammation. 2022; 46(2):573-583.

PMID: 36282372 PMC: 10024662. DOI: 10.1007/s10753-022-01756-4.

An Overview on Immunogenic Cell Death in Cancer Biology and Therapy.

Correa Rodrigues M, Morais J, Ganassin R, Oliveira G, Costa F, Morais A Pharmaceutics. 2022; 14(8).

PMID: 36015189 PMC: 9413301. DOI: 10.3390/pharmaceutics14081564.

Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.

Birmpilis A, Paschalis A, Mourkakis A, Christodoulou P, Kostopoulos I, Antimissari E Cells. 2022; 11(9).

PMID: 35563721 PMC: 9102069. DOI: 10.3390/cells11091415.

References

Hermisson M, Strik H, Rieger J, Dichgans J, Meyermann R, Weller M . Expression and functional activity of heat shock proteins in human glioblastoma multiforme. Neurology. 2000; 54(6):1357-65. DOI: 10.1212/wnl.54.6.1357. View

Strik H, Weller M, Frank B, Hermisson M, Deininger M, Dichgans J . Heat shock protein expression in human gliomas. Anticancer Res. 2001; 20(6B):4457-62. View

Ricaniadis N, Kataki A, Agnantis N, Androulakis G, Karakousis C . Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur J Surg Oncol. 2001; 27(1):88-93. DOI: 10.1053/ejso.1999.1018. View

Multhoff G, Pfister K, Gehrmann M, Hantschel M, Gross C, Hafner M . A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity. Cell Stress Chaperones. 2002; 6(4):337-44. PMC: 434416. DOI: 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2. View

Sagol O, Tuna B, Coker A, Karademir S, Obuz F, Astarcioglu H . Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival. Pathol Res Pract. 2002; 198(2):77-84. DOI: 10.1078/0344-0338-00190. View

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

Hegi M, Diserens A, Gorlia T, Hamou M, De Tribolet N, Weller M . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003. DOI: 10.1056/NEJMoa043331. View

Gastpar R, Gehrmann M, Bausero M, Asea A, Gross C, Schroeder J . Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 2005; 65(12):5238-47. PMC: 1785299. DOI: 10.1158/0008-5472.CAN-04-3804. View

Hau P, Stupp R, Hegi M . MGMT methylation status: the advent of stratified therapy in glioblastoma?. Dis Markers. 2007; 23(1-2):97-104. PMC: 3851641. DOI: 10.1155/2007/159242. View

10.

Mambula S, Stevenson M, Ogawa K, Calderwood S . Mechanisms for Hsp70 secretion: crossing membranes without a leader. Methods. 2007; 43(3):168-75. PMC: 2745244. DOI: 10.1016/j.ymeth.2007.06.009. View

11.

Multhoff G . Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods. 2007; 43(3):229-37. DOI: 10.1016/j.ymeth.2007.06.006. View

12.

Kampinga H, Hageman J, Vos M, Kubota H, Tanguay R, Bruford E . Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2008; 14(1):105-11. PMC: 2673902. DOI: 10.1007/s12192-008-0068-7. View

13.

Bettstetter M, Dechant S, Ruemmele P, Vogel C, Kurz K, Morak M . MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples. Lab Invest. 2008; 88(12):1367-75. DOI: 10.1038/labinvest.2008.100. View

14.

Shin E, Ryu H, Kim S, Jung H, Jang J, Lee K . The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2011; 18(4):544-50. DOI: 10.1007/s00534-010-0367-0. View

15.

Tavassol F, Starke O, Kokemuller H, Wegener G, Muller-Tavassol C, Gellrich N . Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer. Head Neck Oncol. 2011; 3:10. PMC: 3055850. DOI: 10.1186/1758-3284-3-10. View

16.

Quillien V, Lavenu A, Karayan-Tapon L, Carpentier C, Labussiere M, Lesimple T . Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of.... Cancer. 2012; 118(17):4201-11. DOI: 10.1002/cncr.27392. View

17.

Bauer K, Nitsche U, Slotta-Huspenina J, Drecoll E, von Weyhern C, Rosenberg R . High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer. Cell Oncol (Dordr). 2012; 35(3):197-205. DOI: 10.1007/s13402-012-0079-3. View

18.

Cai M, Wang X, Zhang J, Han H, Liu C, Bei J . Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis. J Transl Med. 2012; 10:96. PMC: 3478221. DOI: 10.1186/1479-5876-10-96. View

19.

Murphy M . The HSP70 family and cancer. Carcinogenesis. 2013; 34(6):1181-8. PMC: 3670260. DOI: 10.1093/carcin/bgt111. View

20.

Lee H, Lee E, Kim S, Roh M, Jung S, Choi Y . Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer. Virchows Arch. 2013; 463(4):489-95. DOI: 10.1007/s00428-013-1461-x. View